These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

586 related items for PubMed ID: 15165029

  • 1. Functional characterization of sphingosine 1-phosphate receptor agonist in human endothelial cells.
    Butler J, Lana D, Round O, LaMontagne K.
    Prostaglandins Other Lipid Mediat; 2004 Jan; 73(1-2):29-45. PubMed ID: 15165029
    [Abstract] [Full Text] [Related]

  • 2. Phosphorylation and action of the immunomodulator FTY720 inhibits vascular endothelial cell growth factor-induced vascular permeability.
    Sanchez T, Estrada-Hernandez T, Paik JH, Wu MT, Venkataraman K, Brinkmann V, Claffey K, Hla T.
    J Biol Chem; 2003 Nov 21; 278(47):47281-90. PubMed ID: 12954648
    [Abstract] [Full Text] [Related]

  • 3. Molecular targets of FTY720 (fingolimod).
    Pitman MR, Woodcock JM, Lopez AF, Pitson SM.
    Curr Mol Med; 2012 Dec 21; 12(10):1207-19. PubMed ID: 22834825
    [Abstract] [Full Text] [Related]

  • 4. Effects of phosphorylation of immunomodulatory agent FTY720 (fingolimod) on antiproliferative activity against breast and colon cancer cells.
    Nagaoka Y, Otsuki K, Fujita T, Uesato S.
    Biol Pharm Bull; 2008 Jun 21; 31(6):1177-81. PubMed ID: 18520051
    [Abstract] [Full Text] [Related]

  • 5. Endothelial barrier protection by FTY720 under hyperglycemic condition: involvement of focal adhesion kinase, small GTPases, and adherens junction proteins.
    Sarai K, Shikata K, Shikata Y, Omori K, Watanabe N, Sasaki M, Nishishita S, Wada J, Goda N, Kataoka N, Makino H.
    Am J Physiol Cell Physiol; 2009 Oct 21; 297(4):C945-54. PubMed ID: 19657053
    [Abstract] [Full Text] [Related]

  • 6. Targeting sphingosine-1-phosphate in hematologic malignancies.
    Stevenson CE, Takabe K, Nagahashi M, Milstien S, Spiegel S.
    Anticancer Agents Med Chem; 2011 Nov 21; 11(9):794-8. PubMed ID: 21707492
    [Abstract] [Full Text] [Related]

  • 7. Sphingosine signalling regulates decidual NK cell angiogenic phenotype and trophoblast migration.
    Zhang J, Dunk CE, Lye SJ.
    Hum Reprod; 2013 Nov 21; 28(11):3026-37. PubMed ID: 24001716
    [Abstract] [Full Text] [Related]

  • 8. Mapping pathways downstream of sphingosine 1-phosphate subtype 1 by differential chemical perturbation and proteomics.
    Gonzalez-Cabrera PJ, Hla T, Rosen H.
    J Biol Chem; 2007 Mar 09; 282(10):7254-64. PubMed ID: 17218309
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. FTY720 inhibits S1P-mediated endothelial healing: relationship to S1P1-receptor surface expression.
    Krump-Konvalinkova V, Chwalla I, Siess W.
    Biochem Biophys Res Commun; 2008 Jun 13; 370(4):603-8. PubMed ID: 18402775
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Sphingosine-1-phosphate, FTY720, and sphingosine-1-phosphate receptors in the pathobiology of acute lung injury.
    Natarajan V, Dudek SM, Jacobson JR, Moreno-Vinasco L, Huang LS, Abassi T, Mathew B, Zhao Y, Wang L, Bittman R, Weichselbaum R, Berdyshev E, Garcia JG.
    Am J Respir Cell Mol Biol; 2013 Jul 13; 49(1):6-17. PubMed ID: 23449739
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Immunosuppressive and anti-angiogenic sphingosine 1-phosphate receptor-1 agonists induce ubiquitinylation and proteasomal degradation of the receptor.
    Oo ML, Thangada S, Wu MT, Liu CH, Macdonald TL, Lynch KR, Lin CY, Hla T.
    J Biol Chem; 2007 Mar 23; 282(12):9082-9. PubMed ID: 17237497
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Individual variation of human S1P₁ coding sequence leads to heterogeneity in receptor function and drug interactions.
    Obinata H, Gutkind S, Stitham J, Okuno T, Yokomizo T, Hwa J, Hla T.
    J Lipid Res; 2014 Dec 23; 55(12):2665-75. PubMed ID: 25293589
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 30.